ABSI is trading 5.6% down at $10.70 in pre-market, pulling back after a strong run over the past week.
- The move appears aligned with broader market weakness and risk-off sentiment hitting tech and biotech names in early trading.
- There are no fresh company-specific headlines or earnings reports released today tied to the downward move.